Literature DB >> 18406943

Processes for quality improvements in radiation oncology clinical trials.

T J FitzGerald1, Marcia Urie, Kenneth Ulin, Fran Laurie, Jeffrey Yorty, Richard Hanusik, Sandy Kessel, Maryann Bishop Jodoin, Gani Osagie, M Giulia Cicchetti, Richard Pieters, Kathleen McCarten, Nancy Rosen.   

Abstract

Quality assurance in radiotherapy (RT) has been an integral aspect of cooperative group clinical trials since 1970. In early clinical trials, data acquisition was nonuniform and inconsistent and computational models for radiation dose calculation varied significantly. Process improvements developed for data acquisition, credentialing, and data management have provided the necessary infrastructure for uniform data. With continued improvement in the technology and delivery of RT, evaluation processes for target definition, RT planning, and execution undergo constant review. As we move to multimodality image-based definitions of target volumes for protocols, future clinical trials will require near real-time image analysis and feedback to field investigators. The ability of quality assurance centers to meet these real-time challenges with robust electronic interaction platforms for imaging acquisition, review, archiving, and quantitative review of volumetric RT plans will be the primary challenge for future successful clinical trials.

Mesh:

Year:  2008        PMID: 18406943      PMCID: PMC2391004          DOI: 10.1016/j.ijrobp.2007.07.2387

Source DB:  PubMed          Journal:  Int J Radiat Oncol Biol Phys        ISSN: 0360-3016            Impact factor:   7.038


  9 in total

1.  Randomized study of intensive MOPP-ABVD with or without low-dose total-nodal radiation therapy in the treatment of stages IIB, IIIA2, IIIB, and IV Hodgkin's disease in pediatric patients: a Pediatric Oncology Group study.

Authors:  M A Weiner; B Leventhal; M L Brecher; R B Marcus; A Cantor; P W Gieser; J L Ternberg; F G Behm; M D Wharam; A R Chauvenet
Journal:  J Clin Oncol       Date:  1997-08       Impact factor: 44.544

2.  Radiotherapy in pediatric medulloblastoma: quality assessment of Pediatric Oncology Group Trial 9031.

Authors:  Raymond Miralbell; T J Fitzgerald; Fran Laurie; Sandy Kessel; Arvin Glicksman; Henry S Friedman; Marcia Urie; James L Kepner; Tianni Zhou; Zhengjia Chen; Pat Barnes; Larry Kun; Nancy J Tarbell
Journal:  Int J Radiat Oncol Biol Phys       Date:  2006-01-18       Impact factor: 7.038

3.  Results of a multi-institutional benchmark test for cranial CT/MR image registration.

Authors:  Kenneth Ulin; Marcia M Urie; Joel M Cherlow
Journal:  Int J Radiat Oncol Biol Phys       Date:  2010-04-08       Impact factor: 7.038

4.  Conformal radiotherapy, reduced boost volume, hyperfractionated radiotherapy, and online quality control in standard-risk medulloblastoma without chemotherapy: results of the French M-SFOP 98 protocol.

Authors:  Christian Carrie; Xavier Muracciole; Frédéric Gomez; Jean-Louis Habrand; Mohamed Benhassel; Martine Mege; Marc Mahé; Philippe Quetin; Jean Philippe Maire; Françoise Soum; Marie Helene Baron; Pierre Clavere; Sophie Chapet; Zineb Gaci; Helene Kolodie; Philippe Maingon; Bernard Vie; Valérie Bernier; Claire Alapetite; Sylvette Hoffstetter; Jacques Grill; Frédéric Lafay
Journal:  Int J Radiat Oncol Biol Phys       Date:  2005-05-31       Impact factor: 7.038

5.  Interobserver variability in the detection of cervical-thoracic Hodgkin's disease by computed tomography.

Authors:  B D Fletcher; A S Glicksman; P Gieser
Journal:  J Clin Oncol       Date:  1999-07       Impact factor: 44.544

6.  Impact of targeting deviations on outcome in medulloblastoma: study of the French Society of Pediatric Oncology (SFOP).

Authors:  C Carrie; S Hoffstetter; F Gomez; V Moncho; F Doz; C Alapetite; X Murraciole; J P Maire; M Benhassel; S Chapet; P Quetin; H Kolodie; J L Lagrange; J C Cuillere; J L Habrand
Journal:  Int J Radiat Oncol Biol Phys       Date:  1999-09-01       Impact factor: 7.038

7.  Failure pattern and factors predictive of local failure in rhabdomyosarcoma: a report of group III patients on the third Intergroup Rhabdomyosarcoma Study.

Authors:  Moody D Wharam; Jane Meza; James Anderson; John C Breneman; Sarah S Donaldson; Thomas J Fitzgerald; Jeff Michalski; Lisa A Teot; Eugene S Wiener; William H Meyer
Journal:  J Clin Oncol       Date:  2004-05-15       Impact factor: 44.544

8.  An evaluation of the relationship between the quality of prophylactic cranial radiotherapy in childhood acute leukemia and institutional experience: a Quality Assurance Review Center-Pediatric Oncology Group study.

Authors:  Edward C Halperin; Fran Laurie; T J Fitzgerald
Journal:  Int J Radiat Oncol Biol Phys       Date:  2002-07-15       Impact factor: 7.038

9.  Current calibration, treatment, and treatment planning techniques among institutions participating in the Children's Oncology Group.

Authors:  Marcia Urie; T J FitzGerald; David Followill; Fran Laurie; Robert Marcus; Jeff Michalski
Journal:  Int J Radiat Oncol Biol Phys       Date:  2003-01-01       Impact factor: 7.038

  9 in total
  18 in total

1.  Failure to adhere to protocol specified radiation therapy guidelines was associated with decreased survival in RTOG 9704--a phase III trial of adjuvant chemotherapy and chemoradiotherapy for patients with resected adenocarcinoma of the pancreas.

Authors:  Ross A Abrams; Kathryn A Winter; William F Regine; Howard Safran; John P Hoffman; Robert Lustig; Andre A Konski; Al B Benson; John S Macdonald; Tyvin A Rich; Christopher G Willett
Journal:  Int J Radiat Oncol Biol Phys       Date:  2011-02-01       Impact factor: 7.038

2.  Developing a multi-institutional PACS archive and designing processes to manage the shift from a film to a digital-based archive.

Authors:  Nicole K Laprise; Richard Hanusik; T J Fitzgerald; Nancy Rosen; Keith S White
Journal:  J Digit Imaging       Date:  2007-10-09       Impact factor: 4.056

3.  Redesigning radiotherapy quality assurance: opportunities to develop an efficient, evidence-based system to support clinical trials--report of the National Cancer Institute Work Group on Radiotherapy Quality Assurance.

Authors:  Justin E Bekelman; James A Deye; Bhadrasain Vikram; Soren M Bentzen; Deborah Bruner; Walter J Curran; James Dignam; Jason A Efstathiou; T J FitzGerald; Coen Hurkmans; Geoffrey S Ibbott; J Jack Lee; Thomas E Merchant; Jeff Michalski; Jatinder R Palta; Richard Simon; Randal K Ten Haken; Robert Timmerman; Sean Tunis; C Norman Coleman; James Purdy
Journal:  Int J Radiat Oncol Biol Phys       Date:  2012-03-15       Impact factor: 7.038

4.  Quality of radiotherapy reporting in randomized controlled trials of Hodgkin's lymphoma and non-Hodgkin's lymphoma: in regard to Bekelman and Yahalom (Int J Radiat Oncol Biol Phys 2009;73:492-498).

Authors:  Thomas J Fitzgerald; Maryann Bishop-Jodoin; M Giulia Cicchetti; Richard Hanusik; Sandy Kessel; Fran Laurie; Kathleen M McCarten; Janaki Moni; Richard S Pieters; Nancy Rosen; Kenneth Ulin; Marcia Urie; Allen R Chauvenet; Louis S Constine; James Deye; Bhadrasain Vikram; Debra Friedman; Robert B Marcus; Nancy P Mendenhall; Jon L Williams; James Purdy; Joel Saltz; Cindy L Schwartz; Keith S White; Suzanne Wolden
Journal:  Int J Radiat Oncol Biol Phys       Date:  2010-05-01       Impact factor: 7.038

5.  NCI-RTOG translational program strategic guidelines for the early-stage development of radiosensitizers.

Authors:  Yaacov Richard Lawrence; Bhadrasain Vikram; James J Dignam; Arnab Chakravarti; Mitchell Machtay; Boris Freidlin; Naoko Takebe; Walter J Curran; Soren M Bentzen; Paul Okunieff; C Norman Coleman; Adam P Dicker
Journal:  J Natl Cancer Inst       Date:  2012-12-10       Impact factor: 13.506

Review 6.  Imaging and Data Acquisition in Clinical Trials for Radiation Therapy.

Authors:  Thomas J FitzGerald; Maryann Bishop-Jodoin; David S Followill; James Galvin; Michael V Knopp; Jeff M Michalski; Mark A Rosen; Jeffrey D Bradley; Lalitha K Shankar; Fran Laurie; M Giulia Cicchetti; Janaki Moni; C Norman Coleman; James A Deye; Jacek Capala; Bhadrasain Vikram
Journal:  Int J Radiat Oncol Biol Phys       Date:  2015-10-24       Impact factor: 7.038

Review 7.  What we have learned: the impact of quality from a clinical trials perspective.

Authors:  Thomas J FitzGerald
Journal:  Semin Radiat Oncol       Date:  2012-01       Impact factor: 5.934

8.  Radiotherapy quality assurance report from children's oncology group AHOD0031.

Authors:  Kavita V Dharmarajan; Debra L Friedman; T J FitzGerald; Kathleen M McCarten; Louis S Constine; Lu Chen; Sandy K Kessel; Matt Iandoli; Fran Laurie; Cindy L Schwartz; Suzanne L Wolden
Journal:  Int J Radiat Oncol Biol Phys       Date:  2015-02-07       Impact factor: 7.038

Review 9.  The Importance of Imaging in Radiation Oncology for National Clinical Trials Network Protocols.

Authors:  Thomas J FitzGerald; Maryann Bishop-Jodoin; Fran Laurie; Elizabeth O'Meara; Christine Davis; Jeffrey Bogart; John Kalapurakal; Marilyn J Siegel; Bapsi Chakravarthy; Paul Okunieff; Bruce Haffty; Jeff Michalski; Kenneth Ulin; David S Followill; Stephen Kry; Michael Knopp; Jun Zhang; Don Rosen; Mark Rosen; Ying Xiao; Lawrence Schwartz; Janaki Moni; Maria Giulia Cicchetti
Journal:  Int J Radiat Oncol Biol Phys       Date:  2018-10-18       Impact factor: 7.038

10.  Compliance with therapeutic guidelines in Radiation Therapy Oncology Group prospective gastrointestinal clinical trials.

Authors:  Christopher G Willett; Jennifer Moughan; Elizabeth O'Meara; James M Galvin; Christopher H Crane; Kathryn Winter; Denise Manfredi; Tyvin A Rich; Rachel Rabinovitch; Robert Lustig; Mitchell Machtay; Walter J Curran
Journal:  Radiother Oncol       Date:  2012-10-17       Impact factor: 6.280

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.